Advances in organ and computer models are raising the prospect that some animal experiments could be eliminated. But there ...

Carlin is a vice president at Pathway Policy Group and a veterinarian. Paragas is the CEO and founder of DVLP Medicines and a virologist. The Food and Drug Administration’s recent decision to phase ...

Add Yahoo as a preferred source to see more of our stories on Google. Futuristic Technology in medical concept to finding corona virus covid 19 by using ai artificial intelligence, machine learning, ...

The FDA is moving away from requiring animal models for investigational new drug (IND) applications for new monoclonal antibodies and some other drug candidates. Animal testing will be "reduced, ...

Many of the medicines in our cupboards and products on our shelves today are tested on animals before they are released to market. But the reality is, most of these tests are a waste of time. More ...

Technical.ly is a free news resource thanks to financial supporters like Certara, a Technical.ly client, which sponsored this article. It was reviewed before publication. Learn more about Certara.

In April of this year, the Food and Drug Administration (FDA) announced a new roadmap that aims to replace animal testing in the development of new drugs with more human-relevant methods. The goal is ...

The last few weeks have been busy for Jim Corbett. Corbett, the CEO of organ-chip developer Emulate, has been fielding requests from potential clients, as well as from early investors who say they ...